These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1513111

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
    Cooper ME, Rumble JR, Gin T, Lim-Joon T.
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
    Duggan KA, Hodge G, Makarious MM, Charlesworth JA.
    Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
    [Abstract] [Full Text] [Related]

  • 11. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes.
    Tang Z, Shou I, Wang LN, Fukui M, Tomino Y.
    Nephron; 1997 May; 76(3):323-30. PubMed ID: 9226234
    [Abstract] [Full Text] [Related]

  • 12. Prevention of hypertension with or without renin-angiotensin system inhibition precludes nephrin loss in the early stage of experimental diabetes mellitus.
    Amazonas RB, Sanita Rde A, Kawachi H, de Faria JB.
    Nephron Physiol; 2007 May; 107(2):p57-64. PubMed ID: 17890883
    [Abstract] [Full Text] [Related]

  • 13. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T, Tikkanen I, Rockell MD, Allen TJ, Johnston CI, Cooper ME, Burrell LM.
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [Abstract] [Full Text] [Related]

  • 14. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
    Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF.
    Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
    [Abstract] [Full Text] [Related]

  • 15. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril.
    Harrap SB, Nicolaci JA, Doyle AE.
    Clin Exp Pharmacol Physiol; 1986 Dec; 13(11-12):753-65. PubMed ID: 3030586
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 17. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK, Werstiuk ES, Lee RM.
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
    Striffler JS, Bhathena SJ, Michaelis OE, Campbell JD, Hansen CT, Scalbert E, Thibault N, Velasquez MT.
    Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621
    [Abstract] [Full Text] [Related]

  • 19. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan 26; 302(6770):210-6. PubMed ID: 1998761
    [Abstract] [Full Text] [Related]

  • 20. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL, Cao Z, Rumble JR, Cooper ME, Johnston CI.
    Am J Hypertens; 1996 Sep 26; 9(9):895-901. PubMed ID: 8879346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.